↓ Skip to main content

Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs

Overview of attention for article published in BMC Infectious Diseases, February 2011
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs
Published in
BMC Infectious Diseases, February 2011
DOI 10.1186/1471-2334-11-45
Pubmed ID
Authors

Bernadette Anna Mullen, Katie Cook, Richard D Moore, Cynthia Rand, Noya Galai, Mary E McCaul, Sheldon Glass, Krisann K Oursler, Gregory M Lucas

Abstract

HIV-infected drug users are at higher risk of non-adherence and poor treatment outcomes than HIV-infected non-drug users. Prior work from our group and others suggests that directly administered antiretroviral therapy (DAART) delivered in opioid treatment programs (OTPs) may increase rates of viral suppression.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
Unknown 63 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 17%
Researcher 10 16%
Student > Ph. D. Student 8 13%
Student > Bachelor 6 9%
Student > Doctoral Student 4 6%
Other 14 22%
Unknown 11 17%
Readers by discipline Count As %
Medicine and Dentistry 25 39%
Nursing and Health Professions 10 16%
Social Sciences 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Psychology 3 5%
Other 7 11%
Unknown 11 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 December 2014.
All research outputs
#20,245,139
of 22,772,779 outputs
Outputs from BMC Infectious Diseases
#6,459
of 7,668 outputs
Outputs of similar age
#186,510
of 198,211 outputs
Outputs of similar age from BMC Infectious Diseases
#29
of 31 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,668 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,211 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.